Syros Pharmaceuticals (SYRS) Q1 2025 Earnings

6MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.85
-0.6
-0.35
-0.1

Details

Expected EPS
-0.6497
Actual EPS
-0.6497
Surprise EPS
0
Surprise Percent
+0%

Description

Syros Pharmaceuticals (SYRS) has reported earnings of -0.6497 per share for Q1 2025.

0 Comments

Share your thoughts